High expression of either SLFN5 or SLFN11 has been reported to be prognostically favorable for lung cancer [24,25], and SLFN11 in particular has also been reported to sensitize lung cancer cells to DNA alkylating agents and poly ADP ribose polymerase (PARP) inhibitors [8,24]. Here, SLFN11 is linked to lung cancer.